The expansion will allow the company to double the number of intraocular lenses manufactured every year to 4 million.
Image credit: Rayner
Rayner has announced the completion of an extensive expansion of its Worthing production facility in the UK in order to double the company’s number of intraocular lenses manufactured every year to 4 million.1 The expansion was decided upon in response to a growth in demand, according to a news release.
Rayner’s purpose-built manufacturing facility was opened in 2017 and has produced every Rayner IOL so far in Worthing, including over 6 million RayOne fully preloaded systems. The RayOne series features the EMV lens platform and Galaxy and Galaxy Toric lenses. The EMV lens platform is a non-diffractive optic that utilizes positive spherical aberration to slightly extend range of focus, while avoiding complications that may arise with diffractive lenses.2 The lens has monofocal levels of contrast sensitivity, dysphotopsia, and high levels of patient satisfaction, according to Rayner.
“We are thrilled to have completed our latest factory expansion,” said Tom Heron, head of manufacturing at Rayner, in the release. “This development enables us to uphold our rigorous quality control standards as we continue to grow – including 4 meticulous inspections of every single IOL. Combined with the opening of our new global warehouse near Gatwick Airport in 2024, this expansion reinforced our commitment to an uninterrupted supply for customers worldwide.”
“Our teams have worked incredible hard to bring this ambitious expansion to life, which included the installation of an additional autoclave, automation, and investing in new energy efficient plant equipment,” said Rayner Chief Operating Officer David Forsythe in the release. “I would like to thank everyone involved for their efforts. As the only British manufacturer of IOLs, we take immense pride in our precise and increasingly sustainable lens production process – and in regularly welcoming surgeons to witness it firsthand.”
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.